Determining the molecular target of a Pseudomonas mosselii lipopeptide for crop biocontrol

Technology
Conceptual
University

Research project investigating xantholysin, a lipopeptide produced by Pseudomonas mosselii, as a biocontrol agent against Fusarium oxysporum crop pathogens. The study aims to determine whether xantholysin's antifungal activity works through membrane permeabilization and ionic leakage, supporting development of natural crop protection solutions.

Overview

This research project investigates the molecular mechanism of xantholysin, a lipopeptide produced by Pseudomonas mosselii, as a potential biocontrol agent against multiple formae speciales of Fusarium oxysporum that infect economically important crops. The study seeks to determine whether xantholysin's antifungal activity operates through membrane permeabilization, causing ionic leakage and cell death in a dose-dependent manner. By elucidating the molecular target of this lipopeptide, the research aims to support the development of natural, biologically-based crop protection strategies that could reduce reliance on conventional fungicides.

Technical specifications

Research approach:

  • Investigating xantholysin, a lipopeptide produced by Pseudomonas mosselii, with demonstrated antifungal activity against Fusarium species
  • Examining whether the mechanism of action involves pore formation in fungal cell membranes
  • Using SYTOX Green uptake assays to assess membrane permeability in the presence of xantholysin
  • Applying propidium iodide staining to visualize membrane damage
  • Measuring potassium ion efflux to quantify ionic leakage
  • Assessing relative conductivity changes to confirm membrane disruption

Key scientific premise:

  • Previous plate-based growth inhibition assays established xantholysin's antifungal properties
  • Comparative analysis with other lipopeptides suggests membrane damage as a likely mechanism
  • The project builds on demonstrated ability of xantholysin-producing P. mosselii to inhibit Fusarium growth
Technology readiness level

This project is in early-stage research. The hypothesis is based on prior studies demonstrating antifungal activity, but the specific molecular target of xantholysin has not yet been investigated. The research team is seeking sponsorship to fund the purification of xantholysin and the execution of membrane permeabilization and ionic leakage assays. The proposed study is expected to take approximately one year to complete, and will provide foundational mechanistic understanding needed to advance xantholysin as a candidate biocontrol product for agricultural applications.


About University of California, Davis

UC Davis is a comprehensive public research university in Northern California, combining a land-grant heritage with an integrated academic health system and a veterinary teaching hospital. Industry engages through co-located clinical and translational facilities in Sacramento, a campus-adjacent research park, pilot-scale food and bioprocessing facilities, and a statewide extension network for field-to-market deployment. Proximity to the Bay Area and California's Central Valley enables rapid collaboration with startups and established enterprises, while corporate relations staff streamline access to faculty, talent, and core labs. Research is supported by competitive federal funding from agencies such as NIH, NSF, USDA, and DOE. A dedicated technology transfer office and venture support programs provide IP management, licensing, and startup formation pathways for industry partnerships.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.